Neidio i'r cynnwys
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Uwch
  • A phase I trial of In-111-huma...
  • Dyfynnu hwn
  • Anfonwch hwn fel neges destun
  • E-bostio hwn
  • Argraffu
  • Allforio Cofnod
    • Allforio i RefWorks
    • Allforio i EndNoteWeb
    • Allforio i EndNote
  • Permanent link
A phase I trial of In-111-human epidermal growth factor in patients with metastatic EGFR-positive breast cancer

A phase I trial of In-111-human epidermal growth factor in patients with metastatic EGFR-positive breast cancer

Manylion Llyfryddiaeth
Prif Awduron: Vallis, K, Reilly, R, Scollard, D, Merante, P, Freeman, M, Lockwood, G, Sabate, K, Brade, A
Fformat: Conference item
Cyhoeddwyd: 2008
  • Daliadau
  • Disgrifiad
  • Eitemau Tebyg
  • Dangos Staff
Disgrifiad
Crynodeb:

Eitemau Tebyg

  • Phase I trial to evaluate the tumor and normal tissue uptake, radiation dosimetry and safety of (111)In-DTPA-human epidermal growth factor in patients with metastatic EGFR-positive breast cancer.
    gan: Vallis, K, et al.
    Cyhoeddwyd: (2014)
  • A phase I clinical trial to evaluate the pharmacokinetics, toxicity and dosimetry of 111-indium-labeled human epidermal growth factor in patients with metastatic breast cancer
    gan: Vallis, K, et al.
    Cyhoeddwyd: (2005)
  • Preclinical pharmacokinetic, biodistribution, toxicology, and dosimetry studies of 111In-DTPA-human epidermal growth factor: an auger electron-emitting radiotherapeutic agent for epidermal growth factor receptor-positive breast cancer.
    gan: Reilly, R, et al.
    Cyhoeddwyd: (2006)
  • Effect of the EGFR density of breast cancer cells on nuclear importation, in vitro cytotoxicity, and tumor and normal-tissue uptake of [111In]DTPA-hEGF.
    gan: Hu, M, et al.
    Cyhoeddwyd: (2007)
  • Amplified delivery of indium-111 to EGFR-positive human breast cancer cells.
    gan: Wang, J, et al.
    Cyhoeddwyd: (2001)

Opsiynau Chwilio

  • Hanes Chwilio
  • Chwiliad Uwch

Canfod Mwy

  • Pori'r Catalog
  • Pori yn ôl y Wyddor
  • Archwiliwch Sianeli
  • Cronfeydd y Cwrs
  • Eitemau Newydd

Angen Help?

  • Awgrymiadau Chwilio
  • Gofynnwch i Lyfrgellydd
  • Cwestiynau Cyffredin